What is Isotretinoin?
Acne Drug Accutane May Not Depress Mood After All
Conclusions: "Our retrospective, population-based study shows no increased risk of depression in patients taking isotretinoin, compared to patients with acne but not taking isotretinoin"
Does isotretinoin cause depression and anxiety in acne patients?
Conclusions: Although the psychiatrists are concerned about the potential psychiatric side effects of isotretinoin, our data support no causal relationship between isotretinoin use and depression in acne patients.
Depression is not common in isotretinoin-treated acne patients
Suicide, depression, and isotretinoin: is there a causal link?
Conclusions: Based on this review, the authors conclude that there is no evidence to support a causal connection between isotretinoin and major depression or suicide
Conclusions: The relationship between isotretinoin and depression is the most debated aspect of isotretinoin therapy. Our results link isotretinoin to an overall improvement in psychological wellbeing, even in patients suffering with stable mental illness.
Isotretinoin, depression and suicide: a review of the evidence
Conclusions: While isotretinoin, used to treat acne vulgaris, has not been demonstrated to be associated with depression or suicide, the possibility of a relatively rare idiosyncratic adverse effect remains.
Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study
Conclusions: We did not find any depressive symptoms or suicide risk caused by isotretinoin. On the contrary, a statistically significant improvement of BDI-II scores was found.
Conclusions: Isotretinoin does not appear to be associated with the development of depression. Thus, denying patients with significant acne an effective medication for fear of developing depression may not be indicated at this point in time.
Isotretinoin and the controversy of psychiatric adverse effects
Conclusions: Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events.
Psychological impact of isotretinoin treatment in patients with moderate and severe acne
Conclusions: The results of this study do not find a significant correlation between the use of isotretinoin and the psychological effects of the drug.
Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis
Conclusions: Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.
Conclusions: This study suggested an association of the use of isotretinoin in patients with acne with significantly improved depression symptoms.
Conclusions: We found that neither isotretinoin nor antibiotic treatment affected the levels of depression, anxiety, and suicide in acne patients. Moreover, both isotretinoin and antibiotic treatment were shown to improve the quality of life, social anxiety, and obsessive-compulsive symptoms in acne patients.
Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics
Conclusions: Acne patients on isotretinoin experienced less depressive symptoms and psychological distress as compared to oral antibiotics
Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin
Conclusions: The results of this study did not reveal a direct relationship between the use of isotretinoin and the development of depression. Furthermore, optimum control and treatment of acne vulgaris have shown to improve depression scores.
Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
Conclusions: Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association
Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis
Conclusions: The evidence from this study does not support monthly laboratory testing for use of standard doses of oral isotretinoin for the standard patient with acne.
Conclusions: There are opportunities to improve the quality of care among patients being treated with isotretinoin for acne by reducing the frequency of lipid and liver function monitoring and by eliminating complete blood count monitoring.
Conclusions: Clinically insignificant and reversible CBC abnormalities, mild to moderate elevation of liver transaminases and serum lipids are the most common laboratory abnormalities in patients with acne treated with oral isotretinoin. Due to these abnormalities are reversible even the isotretinoin therapy continued, and generally there is no need to discontinuation of treatment due to laboratory abnormalities, frequent biochemical monitoring is not recommended.
Conclusions: Routine monitoring of white blood cell count, hemoglobin level, and platelet count during isotretinoin therapy may be of little utility without clinical suspicion of an abnormality.
Isotretinion and Inflammatory
Bowel Disease
Isotretinoin exposure and risk of inflammatory bowel disease
Conclusions: Our study did not show an increased risk of IBD with prior isotretinoin use. If anything, the risk seemed to be decreased. Although these results may be due to chance given the small number of IBD cases, the anti-inflammatory and immune-modulating effects of isotretinoin may be worth exploring.
Isotretinoin and risk of inflammatory bowel disease: a French nationwide study
Conclusions: In this population-based case-control study, isotretinoin use was not associated with increased UC risk but was associated with a decreased CD risk. This study provides reassuring data for people using isotretinoin.
Conclusions: Isotretinoin exposure is not associated with an increased risk of developing both ulcerative colitis and Crohn's disease.
Conclusions: IBD incidence among isotretinoin-exposed patients with Acne Vulgaris is very low, and the risk appears similar to that for unexposed patients with Acne Vulgaris.